Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for several ...
pharmaphorum3y
FDA okays Viatris' insulin drug as first 'interchangeable' biosimilar
Lantus – said to be the most administered basal insulin across the world – continues to make blockbuster sales, bringing in almost $775 million for Sanofi in the first quarter of this year.
pharmaphorum19h
Patients resist Novo Nordisk plan to stop making Levemir
Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine ... That shorter half-life makes it easier to adjust ...